Familial Isolated Hyperparathyroidism Overview

Save information for later
Sign Up

Learn About Familial Isolated Hyperparathyroidism

What is the definition of Familial Isolated Hyperparathyroidism?
Familial isolated hyperparathyroidism (FIHP) is an inherited form of primary hyperparathyroidism that is not associated with other features. In FIHP, tumors involving the parathyroid glands cause the production and release of excess parathyroid hormone, which in turn causes increased calcium in the blood (hypercalcemia). The tumors are usually benign, but a cancerous tumor can develop in rare cases. Abnormal levels of calcium cause many of the symptoms of FIHP, including kidney stones, nausea, vomiting, high blood pressure (hypertension), weakness, and fatigue. Osteoporosis often also develops. FIHP may be caused by genetic changes in the MEN1, CDC73 (also known as the HRPT2 gene), or CASR genes and is typically inherited in an autosomal dominant manner. In some cases, the cause is unknown. Genetic changes in the MEN1 and CDC73 genes cause other conditions in which hyperparathyroidism is one of many features, but some people with genetic changes in these genes have only isolated hyperparathyroidism.
What are the alternative names for Familial Isolated Hyperparathyroidism?
  • Familial isolated hyperparathyroidism
  • FIHP
  • Familial primary hyperparathyroidism
  • HRPT1
  • Hyperparathyroidism 1
  • Hyperparathyroidism, familial isolated primary
Who are the top Familial Isolated Hyperparathyroidism Local Doctors?
Randall P. Scheri
Distinguished in Familial Isolated Hyperparathyroidism
Dr. Randall P. Scheri
General Surgery | Surgical Oncology
Distinguished in Familial Isolated Hyperparathyroidism
Dr. Randall P. Scheri
General Surgery | Surgical Oncology

Duke Ambulatory Surgery Center

2400 Pratt St, 
Durham, NC 
919-668-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Randall Scheri is a General Surgeon and a Surgical Oncologist in Durham, North Carolina. Dr. Scheri is rated as a Distinguished provider by MediFind in the treatment of Familial Isolated Hyperparathyroidism. His top areas of expertise are Thyroid Cancer, Hyperparathyroidism, Parathyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Scheri is currently accepting new patients.

Electron Kebebew
Elite in Familial Isolated Hyperparathyroidism
Dr. Electron Kebebew
General Surgery
Elite in Familial Isolated Hyperparathyroidism
Dr. Electron Kebebew
General Surgery

Stanford Health Care

300 Pasteur Dr, 
Stanford, CA 
650-723-4000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Electron Kebebew is a General Surgeon in Stanford, California. Dr. Kebebew is rated as an Elite provider by MediFind in the treatment of Familial Isolated Hyperparathyroidism. His top areas of expertise are Adrenal Cancer, Pheochromocytoma, Anaplastic Thyroid Cancer, Parathyroidectomy, and Thyroidectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Michael T. Stang
Distinguished in Familial Isolated Hyperparathyroidism
Dr. Michael T. Stang
General Surgery | Surgical Oncology
Distinguished in Familial Isolated Hyperparathyroidism
Dr. Michael T. Stang
General Surgery | Surgical Oncology

Duke Ambulatory Surgery Center

2400 Pratt St, 
Durham, NC 
919-668-2000
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Stang is a General Surgeon and a Surgical Oncologist in Durham, North Carolina. Dr. Stang is rated as a Distinguished provider by MediFind in the treatment of Familial Isolated Hyperparathyroidism. His top areas of expertise are Hyperparathyroidism, Thyroid Nodule, Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Stang is currently accepting new patients.

View All Doctors
What are the latest Familial Isolated Hyperparathyroidism Clinical Trials?
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Genetic Bases of Neuroendocrine Neoplasms in Mexican Patients
Enrollment Status: Recruiting
Publish Date: July 26, 2024

Summary: Neuroendocrine neoplasms (NENs) are a heterogeneous group of lesions derived from cells with the ability to produce hormones that may arise from multiple different organs. Their clinical behavior is quite variable, encompassing both benign lesions and aggressive tumors that invade surrounding and/or distant structures. NENs may also cause serious morbidity due to hormone oversecretion. NENs are am...

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center